Clínic Barcelona
Research

Hospital Clínic-IDIBAPS researchers review adjuvant treatment with immunotherapy and vaccines for liver cancer

Researchers from the Hospital Clínic-IDIBAPS have published a review in Nature Reviews Clinical Oncology about the adjuvant and neoadjuvant treatment of the most common liver cancer, hepatocellular carcinoma. The article assesses the mechanisms of action of immunotherapy and vaccines in adjuvant and neoadjuvant treatment before and after surgery or local ablation, analyses the results of the positive phase III clinical trial with Atezolizumab plus Bevacizumab as adjuvant treatment, and reviews clinical trials with immunotherapies with more promising results.  

Josep M. Llovet, leader of the article, and Roser Pinyol, co-author of the article

Josep M. Llovet, leader of the article, and Roser Pinyol, co-author of the article

Keep reading about: